Engineering a multi-target therapy nanoplatform against tumor growth and metastasis via a novel NSAID-Pt(iv) prodrug

Tumor growth and metastasis are caused by many factors. The complexity means that a multi-target combination therapy strategy should be selected against tumor growth and metastasis. Here, cisplatin (CDDP) and bendazac (Ben) were designed as a novel NSAID-Pt(iv) nanoplatform, which is an effective weapon for combating tumor growth and metastasis.